| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | +117.6% |
| R&D Expense | $112.8M | +80.8% |
| SG&A Expense | $39.7M | +39.4% |
| Operating Income | -$145.8M | -66.0% |
| Interest Expense | $861K | +0.0% |
| Income Tax | $0 | — |
| Net Income | -$141.8M | -57.2% |
| EPS (Basic) | -$3.49 | -21.2% |
| EPS (Diluted) | -$3.49 | -21.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $292.4M | +13.7% |
| Short-term Investments | $403.3M | — |
| Accounts Receivable | $1.0M | -4.6% |
| Current Assets | $708.2M | +166.8% |
| Total Assets | $740.8M | +176.6% |
| Current Liabilities | $22.8M | +38.8% |
| Total Liabilities | $64.8M | +98.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$123.3M | -94.1% |
| Capital Expenditures | $2.7M | +137.9% |
| Investing Cash Flow | -$403.8M | — |
| Financing Cash Flow | $562.2M | +110.0% |
| Free Cash Flow | -$126.0M | -94.9% |
| Stockholders' Equity |
| $676.0M |
| +187.5% |